3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Smoking Cessation
11
Tobacco Use Disorder
7
Smoking
5
Lung Neoplasms
5
Uterine Cervical Neoplasms
4
Tobacco Use Cessation
4
Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Tobacco Use
2
Tobacco Smoking
2
Small Cell Lung Carcinoma
2
Head and Neck Neoplasms
2
Cigarette Smoking
2
Acquired Immunodeficiency Syndrome
2
Urinary Bladder Neoplasms
1
Tongue Neoplasms
1
Substance-Related Disorders
1
Stomach Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Overweight
1
Oropharyngeal Neoplasms
1
Neoplasms, Second Primary
1
Nasopharyngeal Neoplasms
1
Mouth Neoplasms
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Laryngeal Neoplasms
1
Interventions
Radiotherapy
2
Radiosurgery
2
Leucovorin
2
Irinotecan
2
Fluorouracil
2
Drug Therapy
2
sacubitril and valsartan sodium hydrate drug combination
1
icotinib
1
dostarlimab
1
beta Carotene
1
avelumab
1
alpha-Tocopherol
1
Varenicline
1
Tyrosine Kinase Inhibitors
1
Trastuzumab
1
Tobacco Use Cessation Devices
1
Therapeutics
1
Thalidomide
1
Temozolomide
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Semen Analysis
1
Registries
1
Probiotics
1
Patient Reported Outcome Measures
1
Panitumumab
1
Nicotine Chewing Gum
1
Myofascial Release Therapy
1
Megestrol Acetate
1
Isotretinoin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neoplasms, Second Primary
×
Tobacco Use Cessation Devices
×
Clear all
NCT04634071
2026-02-02
TTOP
University of Kentucky
Phase 2
Completed
126 enrolled